Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 2016, Article ID 5780538, 7 pages
http://dx.doi.org/10.1155/2016/5780538
Research Article

Detection of OSR2, VAV3, and PPFIA3 Methylation in the Serum of Patients with Gastric Cancer

1The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, Shaanxi, China
2No. 2 Subsidiary Hospital of No. 4 Military Medical University, Xi’an, Shaanxi, China

Received 28 December 2015; Revised 19 February 2016; Accepted 2 March 2016

Academic Editor: Stamatios Theocharis

Copyright © 2016 Wen-han Li et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. A. González, N. Sala, and T. Rokkas, “Gastric cancer: epidemiologic aspects,” Helicobacter, vol. 18, supplement 1, pp. 34–38, 2013. View at Publisher · View at Google Scholar
  2. H. Zhang, L.-L. Sun, Y.-L. Meng et al., “Survival trends in gastric cancer patients of Northeast China,” World Journal of Gastroenterology, vol. 17, no. 27, pp. 3257–3262, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. D. S. Shames, J. D. Minna, and A. F. Gazdar, “DNA methylation in health, disease, and cancer,” Current Molecular Medicine, vol. 7, no. 1, pp. 85–102, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. J.-P. J. Issa, N. Ahuja, M. Toyota, M. P. Bronner, and T. A. Brentnall, “Accelerated age-related CpG island methylation in ulcerative colitis,” Cancer Research, vol. 61, no. 9, pp. 3573–3577, 2001. View at Google Scholar · View at Scopus
  5. T. Maekita, K. Nakazawa, M. Mihara et al., “High levels of aberrant DNA methylation in Helicobacter pylori-infected gastric mucosae and its possible association with gastric cancer risk,” Clinical Cancer Research, vol. 12, no. 3 I, pp. 989–995, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. J.-Y. Choi, S. R. James, P. A. Link et al., “Association between global DNA hypomethylation in leukocytes and risk of breast cancer,” Carcinogenesis, vol. 30, no. 11, pp. 1889–1897, 2009. View at Publisher · View at Google Scholar
  7. X.-P. Zou, B. Zhang, X.-Q. Zhang, M. Chen, J. Cao, and W.-J. Liu, “Promoter hypermethylation of multiple genes in early gastric adenocarcinoma and precancerous lesions,” Human Pathology, vol. 40, no. 11, pp. 1534–1542, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. K. B. Sriram, V. Relan, B. E. Clarke et al., “Diagnostic molecular biomarkers for malignant pleural effusions,” Future Oncology, vol. 7, no. 6, pp. 737–752, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. T. Wu, E. Giovannucci, J. Welge, P. Mallick, W.-Y. Tang, and S.-M. Ho, “Measurement of GSTP1 promoter methylation in body fluids may complement PSA screening: a meta-analysis,” British Journal of Cancer, vol. 105, no. 1, pp. 65–73, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. L. Li, J.-Y. Choi, K.-M. Lee et al., “DNA methylation in peripheral blood: a potential biomarker for cancer molecular epidemiology,” Journal of Epidemiology, vol. 22, no. 5, pp. 384–394, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. J. Zhou, Y.-H. Shi, and J. Fan, “Circulating cell-free nucleic acids: promising biomarkers of hepatocellular carcinoma,” Seminars in Oncology, vol. 39, no. 4, pp. 440–448, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. K. Hibi, T. Goto, A. Shirahata et al., “Detection of TFPI2 methylation in the serum of gastric cancer patients,” Anticancer Research, vol. 31, no. 11, pp. 3835–3838, 2011. View at Google Scholar · View at Scopus
  13. L. Chen, L. Su, J. Li et al., “Hypermethylated FAM5C and MYLK in serum as diagnosis and pre-warning markers for gastric cancer,” Disease Markers, vol. 32, no. 3, pp. 195–202, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. A. Shirahata, K. Sakuraba, Y. Kitamura et al., “Detection of vimentin methylation in the serum of patients with gastric cancer,” Anticancer Research, vol. 32, no. 3, pp. 791–794, 2012. View at Google Scholar · View at Scopus
  15. M. Barchitta, A. Quattrocchi, A. Maugeri, M. Vinciguerra, and A. Agodi, “LINE-1 hypomethylation in blood and tissue samples as an epigenetic marker for cancer risk: a systematic review and meta-analysis,” PLoS ONE, vol. 9, no. 10, Article ID 0109478, 2014. View at Publisher · View at Google Scholar · View at Scopus
  16. Y.-C. Wu, P. Lv, J. Han et al., “Enhanced serum methylated p16 DNAs is associated with the progression of gastric cancer,” International Journal of Clinical and Experimental Pathology, vol. 7, no. 4, pp. 1553–1562, 2014. View at Google Scholar · View at Scopus
  17. Y. Zhang, H. J. Su, K. F. Pan et al., “Methylation status of blood leukocyte DNA and risk of gastric cancer in a high-risk Chinese population,” Cancer Epidemiology Biomarkers & Prevention, vol. 23, no. 10, pp. 2019–2026, 2014. View at Publisher · View at Google Scholar
  18. I. Balgkouranidou, D. Matthaios, A. Karayiannakis et al., “Prognostic role of APC and RASSF1A promoter methylation status in cell free circulating DNA of operable gastric cancer patients,” Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, vol. 778, pp. 46–51, 2015. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Bibikova, Z. Lin, L. Zhou et al., “High-throughput DNA methylation profiling using universal bead arrays,” Genome Research, vol. 16, no. 3, pp. 383–393, 2006. View at Publisher · View at Google Scholar · View at Scopus
  20. L. Zong, N. Hattori, Y. Yoda et al., “Establishment of a DNA methylation marker to evaluate cancer cell fraction in gastric cancer,” Gastric Cancer, 2015. View at Publisher · View at Google Scholar · View at Scopus
  21. S. Kawai and A. Amano, “Odd-skipped related 2 is epigenetically regulated in cellular quiescence,” Biochemical and Biophysical Research Communications, vol. 396, no. 4, pp. 831–836, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. S. Kawai, Y. Abiko, and A. Amano, “Odd-skipped related 2 regulates genes related to proliferation and development,” Biochemical and Biophysical Research Communications, vol. 398, no. 2, pp. 184–190, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. B.-B. Tan, M.-M. Zhang, Y. Li et al., “Inhibition of Vav3 gene can promote apoptosis of human gastric cancer cell line MGC803 by regulating ERK pathway,” Tumor Biology, 2015. View at Publisher · View at Google Scholar
  24. S. E. Cottrell and P. W. Laird, “Sensitive detection of DNA methylation,” Annals of the New York Academy of Sciences, vol. 983, pp. 120–130, 2003. View at Publisher · View at Google Scholar · View at Scopus
  25. V. V. Vlassov, P. P. Laktionov, and E. Y. Rykova, “Circulating nucleic acids as a potential source for cancer biomarkers,” Current Molecular Medicine, vol. 10, no. 2, pp. 142–165, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. G. H. Kang, S. Lee, J.-S. Kim, and H.-Y. Jung, “Profile of aberrant CpG island methylation along the multistep pathway of gastric carcinogenesis,” Laboratory Investigation, vol. 83, no. 5, pp. 635–641, 2003. View at Publisher · View at Google Scholar · View at Scopus
  27. M. F. G. de Maat, C. J. H. van de Velde, N. Umetani et al., “Epigenetic silencing of cyclooxygenase-2 affects clinical outcome in gastric cancer,” Journal of Clinical Oncology, vol. 25, no. 31, pp. 4887–4894, 2007. View at Publisher · View at Google Scholar · View at Scopus
  28. M. Ye, B. Xia, Q. Guo, F. Zhou, and X. Zhang, “Association of diminished expression of RASSF1A with promoter methylation in primary gastric cancer from patients of central China,” BMC Cancer, vol. 7, article 120, 2007. View at Publisher · View at Google Scholar · View at Scopus
  29. P. Gu, X. Xing, M. Tänzer et al., “Frequent loss of TIMP-3 expression in progression of esophageal and gastric adenocarcinomas,” Neoplasia, vol. 10, no. 6, pp. 563–572, 2008. View at Publisher · View at Google Scholar · View at Scopus
  30. K. Hosoya, S. Yamashita, T. Ando, T. Nakajima, F. Itoh, and T. Ushijima, “Adenomatous polyposis coli 1A is likely to be methylated as a passenger in human gastric carcinogenesis,” Cancer Letters, vol. 285, no. 2, pp. 182–189, 2009. View at Publisher · View at Google Scholar · View at Scopus
  31. J. G. Herman, J. R. Graff, S. Myöhänen, B. D. Nelkin, and S. B. Baylin, “Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands,” Proceedings of the National Academy of Sciences of the United States of America, vol. 93, no. 18, pp. 9821–9826, 1996. View at Publisher · View at Google Scholar · View at Scopus
  32. B. Vogelstein and K. W. Kinzler, “Digital PCR,” Proceedings of the National Academy of Sciences of the United States of America, vol. 96, no. 16, pp. 9236–9241, 1999. View at Publisher · View at Google Scholar · View at Scopus
  33. C. M. Sturgeon, B. R. Hoffman, D. W. Chan et al., “National academy of clinical biochemistry laboratory medicine practice guidelines for use of tumor markers in clinical practice: quality requirements,” Clinical Chemistry, vol. 54, no. 8, pp. e1–e10, 2008. View at Publisher · View at Google Scholar · View at Scopus
  34. S. U. Meyer, M. W. Pfaffl, and S. E. Ulbrich, “Normalization strategies for microRNA profiling experiments: a ‘normal’ way to a hidden layer of complexity?” Biotechnology Letters, vol. 32, no. 12, pp. 1777–1788, 2010. View at Publisher · View at Google Scholar · View at Scopus
  35. Y. Toiyama, Y. Okugawa, and A. Goel, “DNA methylation and microRNA biomarkers for noninvasive detection of gastric and colorectal cancer,” Biochemical and Biophysical Research Communications, vol. 455, no. 1-2, pp. 43–57, 2014. View at Publisher · View at Google Scholar · View at Scopus